Director of BLMH (NASDAQ: BLMH) awarded 64,082 shares as compensation
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
BioLife Holdings, Inc. reported a director stock award. Director Bradley Laurence Hirsch received 64,082 shares of common stock on December 31, 2025, as compensation for his service on the board. The implied price was $0.98 per share, and he now beneficially owns 64,082 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
HIRSCH BRADLEY LAURENCE
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 64,082 | $0.98 | $63K |
Holdings After Transaction:
Common Stock — 64,082 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did BLMH disclose about director Bradley Hirsch in this Form 4?
BLMH disclosed that director Bradley Laurence Hirsch received 64,082 shares of common stock as compensation. The shares were issued on December 31, 2025, at an implied price of $0.98 per share, and he now directly beneficially owns 64,082 shares.
Was the BLMH insider transaction a purchase or compensation grant?
The BLMH insider transaction was a compensation grant, not a market purchase. The company issued 64,082 common shares to director Bradley Hirsch on December 31, 2025 as payment for his board service, at an implied price of $0.98 per share.
Is Bradley Hirsch’s BLMH ownership direct or through an entity?
Bradley Hirsch’s BLMH holdings reported in this filing are held directly. The Form 4 identifies the ownership form as direct, with 64,082 common shares beneficially owned, and includes no footnote indicating an intermediary entity, trust, or partnership.